Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.

Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.

Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.

Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.

Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.

Abstract: An electrostatic capacitance type touch sensor is provided. The touch sensor includes a substrate and a grid pattern formed on a surface of the substrate by a plurality of first linear wires and a plurality of second linear wires, the first linear wires being arranged parallel to each other at a predetermined interval, and the second linear wires being arranged parallel to each other at a predetermined interval and intersecting with the first linear wires. A separation portion is provided to the first linear wires and the second linear wires to form a sensor portion and a dummy sensor portion which are located next to each other and electrically separated from each other.

Abstract: A fluorescent display device is disclosed. The fluorescent display device includes an anode plate, aluminum anode wirings arranged on the anode plate, a first light shielding aluminum film arranged on the anode plate, an insulation layer arranged on both the anode wiring and the first light shielding film, a second light shielding graphite film arranged on the insulation layer, an anode electrode arranged on the insulation layer, and an outer light source display formed by removing a portion of the first light shielding film. The outer light source display is illuminated by a LED to display a predetermined pattern. The second light shielding film is formed along a wiring array arranged on the first light shielding film and the wiring so that a gap between the first light shielding film and the wirings is covered with the second light shielding film.

Abstract: The present invention is directed to compounds for use in the treatment or prevention of influenza virus infection.

Abstract: A fluorescent display device is disclosed. The fluorescent display device includes an anode plate, aluminum anode wirings arranged on the anode plate, a first light shielding aluminum film arranged on the anode plate, an insulation layer arranged on both the anode wiring and the first light shielding film, a second light shielding graphite film arranged on the insulation layer, an anode electrode arranged on the insulation layer, and an outer light source display formed by removing a portion of the first light shielding film. The outer light source display is illuminated by a LED to display a predetermined pattern. The second light shielding film is formed along a wiring array arranged on the first light shielding film and the wiring so that a gap between the first light shielding film and the wirings is covered with the second light shielding film.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of P13-kinase activity.

Abstract: An electrostatic capacitance type touch sensor is provided. The touch sensor includes a substrate and a grid pattern formed on a surface of the substrate by a plurality of first linear wires and a plurality of second linear wires, the first linear wires being arranged parallel to each other at a predetermined interval, and the second linear wires being arranged parallel to each other at a predetermined interval and intersecting with the first linear wires. A separation portion is provided to the first linear wires and the second linear wires to form a sensor portion and a dummy sensor portion which are located next to each other and electrically separated from each other.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of P13-kinase activity.

Abstract: A compound of Formula (I): or a salt or solvate thereof, wherein: One of R1 and R2 is H and the other represents —NHCONHR4, wherein R4 represents a phenyl or naphthyl group which may be optionally substituted by one or more substituents independently selected from —C1-6 alkyl, —C1-6 haloalkyl, halogen, C1-6 alkoxy, C1-6 haloalkoxy, OH, NO2, C3-7 cycloalkyl, indanyl, or R4 together with the NH to which it is bonded forms a morpholino group; and R3 is H or NHR5 wherein R5 is H, -quinolinyl or -isoquinolinyl, —(CONH)p phenyl wherein p is 0 or 1 and the phenyl is optionally substituted by one or more substituents independently selected from halogen, —C1-6 alkyl, —C1-6 haloalkyl, -morpholino, —SO2NH2, and methyl substituted benzothiazole.

Abstract: This invention relates to newly identified inhibitors of kinases for treating various disorders.

Abstract: Benzimidazole derivatives, which are useful as TIE-2 and/or VEGFR2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Abstract: Benzimidazole derivatives, which are useful as TIE-2 and/or VEGFR2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Abstract: This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 proteins.

Abstract: A compound of Formula (I): or a salt or solvate thereof, wherein R1 represents a phenyl or napthyl group, each of which is substituted by one or more substituents independently selected from —OH, —C1-6alkyl, C1-6haloalkyl, —OCH2OCH3, —C1-6alkoxy, and -halogen, or a mono or bicyclic heteroaryl group comprising 1, 2 or 3 nitrogen atoms, optionally substituted by —C1-6alkoxy, —C1-6alkyl, C1-6haloalkyl or ?O; R2 represents H, benzimidazolyl, benzothiazolyl, piperonyl, isoquinolinyl, quinolinyl, or phenyl wherein said phenyl is optionally substituted by —NR3R4, —C1-4alkoxy, —C1-6alkyl, —CONR3R4, —SO2NR 3R4, —NHCONR3R4, —NHCOC1-6alkyl, —C1-6haloalkyl, phenoxy, NH2 substituted phenoxy, —C1-3alkyl, —C1-3alkoxy, —CF3, or -5 membered heteroaryl group comprising one or two nitrogen atoms; R3 and R4 are independently selected from H, —C1-6alkyl, —C1-3alkylNR5R6; and R5 and R6 are independently H or C1-3alkyl.

Abstract: This invention relates to newly identified inhibitors of kinases for treating various disorders.

Abstract: Benzimidazole derivatives, which are useful as TIE-2 and/or VEGFR2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.